Non-dipping blood pressure profile in narcolepsy with cataplexy

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Dauvilliers, Yves ^a,b,c   Jaussent, Isabelle ^b,c   Krams, Benjamin ^a   Scholz, Sabine ^a   Lado, Stéphane ^a,d   Levy, Patrick ^d   Pepin, Jean Louis ^d  

^a GUI DE CHAULIAC HOSPITAL   (France)

^b INSERM   (France)

^c UNIV MONTPELLIER   (France)

^d Domaine de la Merci   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYBUTYRIC ACID; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; C REACTIVE PROTEIN; CLOMIPRAMINE; METHYLPHENIDATE; MODAFINIL; OREXIN; VENLAFAXINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CATAPLEXY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; FEMALE; GENDER; HEART RATE VARIABILITY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MALE; METABOLIC SYNDROME X; NARCOLEPSY; OBESITY; POLYSOMNOGRAPHY; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY; PULSE RATE; REM SLEEP; RISK ASSESSMENT; SLEEP QUALITY; SMOKING; SYSTOLIC BLOOD PRESSURE; TONOMETRY; WAIST CIRCUMFERENCE;

ADOLESCENT; ADULT; AGED; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CASE-CONTROL STUDIES; CATAPLEXY; DIASTOLE; ENDOTHELIUM; FEMALE; HUMANS; MALE; MIDDLE AGED; NARCOLEPSY; POLYSOMNOGRAPHY; PULSE; SLEEP; SYSTOLE; YOUNG ADULT;

CINCLIDAE;

EID: 84863108836     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038977     Document Type: Article

References (36)

1. Dauvilliers Y, Arnulf I, Mignot E, (2007) Narcolepsy with cataplexy. Lancet 369: 499-511.
2. Plazzi G, Serra L. Ferri R, (2008) Nocturnal aspects of narcolepsy with cataplexy. Sleep Med. Rev (12): 109-128.
3. Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, et al. (2000) A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med6: 991-7.
4. Mignot E, Lammers GJ, Ripley B, Okun M, Nevsimalova S, et al. (2002) The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol59: 1553-62.
5. Shirasaka T, Kunitake T, Takasaki M, Kannan H, (2002) Neuronal effects of orexins: relevant to sympathetic and cardiovascular functions. Regul Pept104: 91-5.
6. Samson WK, Taylor MM, Ferguson AV, (2005) Non-sleep effects of hypocretin/orexin. Sleep Med Rev9: 243-52.
7. Shirasaka T, Nakazato M, Matsukura S, Takasaki M, Kannan H, (1999) Sympathetic and cardiovascular actions of orexins in conscious rats. Am J Physiol277: R1780-5.
8. Kayaba Y, Nakamura A, Kasuya Y, Ohuchi T, Yanagisawa M, et al. (2003) Attenuated defense response and low basal blood pressure in orexin knockout mice. Am J Physiol Regul Integr Comp Physiol285: R581-93.
9. Bastianini S, Silvani A, Berteotti C, Elghozi JL, Franzini C, et al. (2011) Sleep related changes in blood pressure in hypocretin-deficient narcoleptic mice. Sleep (34): 213-8.
10. Smith PM, Connolly BC, Ferguson AV, (2002) Microinjection of orexin into the rat nucleus tractus solitarius causes increases in blood pressure. Brain Res950: 261-7.
11. de Oliveira CV, Rosas-Arellano MP, Solano-Flores LP, Ciriello J, (2003) Cardiovascular effects of hypocretin-1 in nucleus of the solitary tract. Am J Physiol Heart Circ Physiol284: H1369-77.
12. Chen CT, Hwang LL, Chang JK, Dun NJ, (2000) Pressor effects of orexins injected intracisternally and to rostral ventrolateral medulla of anesthetized rats. Am J Physiol Regul Integr Comp Physiol278: R692-7.
13. Poli F, Plazzi G, Di Dalmazi G, Ribichini D, Vicennati V, et al. (2009) Body mass index-independent metabolic alterations in narcolepsy with cataplexy. Sleep32: 1491-7.
14. Smolensky MH, Hermida RC, Castriotta RJ, Portaluppi F, (2007) Role of sleep-wake cycle on blood pressure circadian rhythms and hypertension. Sleep Med (8): 668-80.
15. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, et al. (2002) Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens 20: 2183-2189.
16. Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, et al. (2005) Superiority of ambulatory over clinic blood pressure measurement in predicting mortality. The Dublin Outcome Study. Hypertension46: 156-161.
17. Ben-Dov IZ, Kark JD, Ben-Ishay D, Mekler J, Ben-Arie L, et al. (2007) Predictors of all cause mortality in clinical ambulatory monitoring. Unique aspects of blood pressure during sleep. Hypertension 49: 1235-1241.
18. Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, et al. (2007) Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet 370: 1219-29.
19. Hansen TW, Jeppesen J, Rasmussen F, Ibsen H, Torp-Pedersen C, (2005) Ambulatory blood pressure monitoring and mortality: a population-based study. Hypertension 45: 499-504.
20. Widlansky ME, Gokce N, Keaney J, Vita J, (2003) The clinical implications of endothelial dysfunction. J Am Coll Cardiol. 42: 1149-60.
21. Rubinshtein R, Kuvin JT, Soffler M, Lennon RJ, Lavi S, et al. (2010) Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. Eur Heart J. 31: 1142-8.
22. Hamburg NM, Keyes MJ, Larson MG, Vasan RS, Schnabel R, et al. (2008) Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation 117: 2467e74.
23. American Academy of Sleep Medicine, (2005) American Academy of Sleep Medicine, Westchester, Illinois. International Classification of Sleep Disorders: Diagnostic and Coding Manual, 2nd Edn.
24. National Cholesterol Education Program Adult Treatment Panel III criteria (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) JAMA 285: 486-97.
25. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
26. Iber C, Ancoli-Israel S, Chesson A, Quan S, (2007) Westchester, IL: American Academy of Sleep Medicine. The AASM Manual for the Scoring of Sleep and Associated Events; Rules, Terminology and Technical Specifications, 1st Edn.
27. Zucconi M, Ferri R, Allen R, Baier PC, Bruni O, et al. (2006) The official World Association of Sleep Medicine (WASM) standards for recording and scoring periodic leg movements in sleep (PLMS) and wakefulness (PLMW) developed in collaboration with a task force from the International Restless Legs Syndrome Study Group (IRLSSG) Sleep Med7: 175-83.
28. Middelkoop HA, Lammers GJ, Van Hilten BJ, Ruwhof C, Pijl H, et al. (1995) Circadian distribution of motor activity and immobility in narcolepsy: assessment with continuous motor activity monitoring. Psychophysiology (32): 286-91.
29. Dauvilliers Y, Pennestri MH, Whittom S, Lanfranchi PA, Montplaisir JY, (2011) Autonomic response to periodic leg movements during sleep in narcolepsy-cataplexy. Sleep (34): 219-23.
30. Thayer J, Yamamoto S, Brosschot J, (2010) The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors. Int J Cardiology 141: 122-31.
31. Kleiger RE, Miller JP, Bigger JT, Moss AJ, (1987) Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol59: 256-62.
32. Somers VK, Dyken ME, Mark AL, Abboud FM, (1993) Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med 328: 303-307.
33. Yoshimoto M, Yoshida I, Miki K, (2011) Functional role of diverse changes in sympathetic nerve activity in regulating arterial pressure during REM sleep. Sleep (34): 1093-101.
34. Grimaldi D, Calandra-Buonaura G, Provini F, Agati P, Pierangeli G, et al. (2012) Abnormal sleep-cardiovascular system interaction in narcolepsy with cataplexy: effects of hypocretin deficiency in humans. Sleep 35: 519-528.
35. Baguet JP, Barone-Rochette G, Pépin JL, (2009) Hypertension and obstructive sleep apnoea syndrome: current perspectives. J Hum Hypertens (23): 431-43.
36. Quinaglia T, Martins LC, Figueiredo VN, Santos RC, Yugar-Toledo JC, et al. (2011) Non-dipping pattern relates to endothelial dysfunction in patients with uncontrolled resistant hypertension. J Hum Hypertens. 25: 656-64.